The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Alcoholic Hepatitis Therapeutic-Global Market Insights and Sales Trends 2024
Synopsis
Alcoholic hepatitis is a kind of liver disease usually affects people who are used to be heavy drinkers. It can cause short and long-term liver damage. Liver is a major organ of body functions to remove poisons such as alcohol from blood. It’s damaged by long time heavy drinking of alcohol. Usually occur in 30% of long- time alcohol drinkers. Asymptomatic steatohepatitis is also as alcoholic hepatitis the term is used to describe the acute onset of symptomatic hepatitis. Symptoms include changes I appetite, dry mouth, yellowing of skin or eyes, weight loss, fever and fatigue. Sometime alcoholic hepatitis could get serious conditions include fluid buildup in the abdomen, confusion or brain fog and bleeding in esophagus or stomach. Treatment for alcoholic hepatitis involves therapies and drinking cessation to ease the sign and symptoms of liver damage. Corticosteroids are the current main treatment for alcoholic hepatitis in patients who do not have contraindication for steroid treatment. Corticosteroids are the medications have shown short-term benefits in increasing survival of certain people suffer with alcoholic hepatitis. Pentoxifylline is recommend to patients who can’t take corticosteroids. Studies indicate that pentoxifylline might not be effective for people with mild alcoholic hepatitis or people who have not respond to steroid treatment.
The global Alcoholic Hepatitis Therapeutic market size is expected to reach US$ 3839.4 million by 2029, growing at a CAGR of 5.3% from 2023 to 2029. The market is mainly driven by the significant applications of Alcoholic Hepatitis Therapeutic in various end use industries. The expanding demands from the Hospitals and Clinics and Research and Development, are propelling Alcoholic Hepatitis Therapeutic market. Monoclonal Antibodies, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Caspase Protease Inhibitor segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Alcoholic Hepatitis Therapeutic, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Alcoholic Hepatitis Therapeutic market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Alcoholic Hepatitis Therapeutic market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Alcoholic Hepatitis Therapeutic sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Alcoholic Hepatitis Therapeutic covered in this report include Alkermes, Conatus pharmaceuticals, Dainippon sumitomo pharma, Generon corporation, Immuron limited, Lupin Laboratories, Intercept Pharmaceuticals, Teva Pharmaceuticals and Sanofi-Aventis, etc.
The global Alcoholic Hepatitis Therapeutic market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Alkermes
Conatus pharmaceuticals
Dainippon sumitomo pharma
Generon corporation
Immuron limited
Lupin Laboratories
Intercept Pharmaceuticals
Teva Pharmaceuticals
Sanofi-Aventis
Global Alcoholic Hepatitis Therapeutic market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Alcoholic Hepatitis Therapeutic market, Segment by Type:
Monoclonal Antibodies
Caspase Protease Inhibitor
Corticosteroids
Hemorheologic Agents
Anabolic Steroids
Hepatotropic Hormones
Sulfhydryl Agents
Others
Global Alcoholic Hepatitis Therapeutic market, by Application
Hospitals and Clinics
Research and Development
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Alcoholic Hepatitis Therapeutic companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Alcoholic hepatitis is a kind of liver disease usually affects people who are used to be heavy drinkers. It can cause short and long-term liver damage. Liver is a major organ of body functions to remove poisons such as alcohol from blood. It’s damaged by long time heavy drinking of alcohol. Usually occur in 30% of long- time alcohol drinkers. Asymptomatic steatohepatitis is also as alcoholic hepatitis the term is used to describe the acute onset of symptomatic hepatitis. Symptoms include changes I appetite, dry mouth, yellowing of skin or eyes, weight loss, fever and fatigue. Sometime alcoholic hepatitis could get serious conditions include fluid buildup in the abdomen, confusion or brain fog and bleeding in esophagus or stomach. Treatment for alcoholic hepatitis involves therapies and drinking cessation to ease the sign and symptoms of liver damage. Corticosteroids are the current main treatment for alcoholic hepatitis in patients who do not have contraindication for steroid treatment. Corticosteroids are the medications have shown short-term benefits in increasing survival of certain people suffer with alcoholic hepatitis. Pentoxifylline is recommend to patients who can’t take corticosteroids. Studies indicate that pentoxifylline might not be effective for people with mild alcoholic hepatitis or people who have not respond to steroid treatment.
The global Alcoholic Hepatitis Therapeutic market size is expected to reach US$ 3839.4 million by 2029, growing at a CAGR of 5.3% from 2023 to 2029. The market is mainly driven by the significant applications of Alcoholic Hepatitis Therapeutic in various end use industries. The expanding demands from the Hospitals and Clinics and Research and Development, are propelling Alcoholic Hepatitis Therapeutic market. Monoclonal Antibodies, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Caspase Protease Inhibitor segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Alcoholic Hepatitis Therapeutic, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Alcoholic Hepatitis Therapeutic market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Alcoholic Hepatitis Therapeutic market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Alcoholic Hepatitis Therapeutic sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Alcoholic Hepatitis Therapeutic covered in this report include Alkermes, Conatus pharmaceuticals, Dainippon sumitomo pharma, Generon corporation, Immuron limited, Lupin Laboratories, Intercept Pharmaceuticals, Teva Pharmaceuticals and Sanofi-Aventis, etc.
The global Alcoholic Hepatitis Therapeutic market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Alkermes
Conatus pharmaceuticals
Dainippon sumitomo pharma
Generon corporation
Immuron limited
Lupin Laboratories
Intercept Pharmaceuticals
Teva Pharmaceuticals
Sanofi-Aventis
Global Alcoholic Hepatitis Therapeutic market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Alcoholic Hepatitis Therapeutic market, Segment by Type:
Monoclonal Antibodies
Caspase Protease Inhibitor
Corticosteroids
Hemorheologic Agents
Anabolic Steroids
Hepatotropic Hormones
Sulfhydryl Agents
Others
Global Alcoholic Hepatitis Therapeutic market, by Application
Hospitals and Clinics
Research and Development
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Alcoholic Hepatitis Therapeutic companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Alcoholic Hepatitis Therapeutic
1.1 Alcoholic Hepatitis Therapeutic Market Overview
1.1.1 Alcoholic Hepatitis Therapeutic Product Scope
1.1.2 Alcoholic Hepatitis Therapeutic Market Status and Outlook
1.2 Global Alcoholic Hepatitis Therapeutic Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Alcoholic Hepatitis Therapeutic Market Size by Region (2018-2029)
1.4 Global Alcoholic Hepatitis Therapeutic Historic Market Size by Region (2018-2023)
1.5 Global Alcoholic Hepatitis Therapeutic Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Alcoholic Hepatitis Therapeutic Market Size (2018-2029)
1.6.1 North America Alcoholic Hepatitis Therapeutic Market Size (2018-2029)
1.6.2 Europe Alcoholic Hepatitis Therapeutic Market Size (2018-2029)
1.6.3 Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size (2018-2029)
1.6.4 Latin America Alcoholic Hepatitis Therapeutic Market Size (2018-2029)
1.6.5 Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size (2018-2029)
2 Alcoholic Hepatitis Therapeutic Market by Type
2.1 Introduction
2.1.1 Monoclonal Antibodies
2.1.2 Caspase Protease Inhibitor
2.1.3 Corticosteroids
2.1.4 Hemorheologic Agents
2.1.5 Anabolic Steroids
2.1.6 Hepatotropic Hormones
2.1.7 Sulfhydryl Agents
2.1.8 Others
2.2 Global Alcoholic Hepatitis Therapeutic Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Alcoholic Hepatitis Therapeutic Historic Market Size by Type (2018-2023)
2.2.2 Global Alcoholic Hepatitis Therapeutic Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Alcoholic Hepatitis Therapeutic Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Alcoholic Hepatitis Therapeutic Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Alcoholic Hepatitis Therapeutic Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Alcoholic Hepatitis Therapeutic Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Alcoholic Hepatitis Therapeutic Revenue Breakdown by Type (2018-2029)
3 Alcoholic Hepatitis Therapeutic Market Overview by Application
3.1 Introduction
3.1.1 Hospitals and Clinics
3.1.2 Research and Development
3.2 Global Alcoholic Hepatitis Therapeutic Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Alcoholic Hepatitis Therapeutic Historic Market Size by Application (2018-2023)
3.2.2 Global Alcoholic Hepatitis Therapeutic Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Alcoholic Hepatitis Therapeutic Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Alcoholic Hepatitis Therapeutic Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Alcoholic Hepatitis Therapeutic Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Alcoholic Hepatitis Therapeutic Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Alcoholic Hepatitis Therapeutic Revenue Breakdown by Application (2018-2029)
4 Alcoholic Hepatitis Therapeutic Competition Analysis by Players
4.1 Global Alcoholic Hepatitis Therapeutic Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Alcoholic Hepatitis Therapeutic as of 2022)
4.3 Date of Key Players Enter into Alcoholic Hepatitis Therapeutic Market
4.4 Global Top Players Alcoholic Hepatitis Therapeutic Headquarters and Area Served
4.5 Key Players Alcoholic Hepatitis Therapeutic Product Solution and Service
4.6 Competitive Status
4.6.1 Alcoholic Hepatitis Therapeutic Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Alkermes
5.1.1 Alkermes Profile
5.1.2 Alkermes Main Business
5.1.3 Alkermes Alcoholic Hepatitis Therapeutic Products, Services and Solutions
5.1.4 Alkermes Alcoholic Hepatitis Therapeutic Revenue (US$ Million) & (2018-2023)
5.1.5 Alkermes Recent Developments
5.2 Conatus pharmaceuticals
5.2.1 Conatus pharmaceuticals Profile
5.2.2 Conatus pharmaceuticals Main Business
5.2.3 Conatus pharmaceuticals Alcoholic Hepatitis Therapeutic Products, Services and Solutions
5.2.4 Conatus pharmaceuticals Alcoholic Hepatitis Therapeutic Revenue (US$ Million) & (2018-2023)
5.2.5 Conatus pharmaceuticals Recent Developments
5.3 Dainippon sumitomo pharma
5.3.1 Dainippon sumitomo pharma Profile
5.3.2 Dainippon sumitomo pharma Main Business
5.3.3 Dainippon sumitomo pharma Alcoholic Hepatitis Therapeutic Products, Services and Solutions
5.3.4 Dainippon sumitomo pharma Alcoholic Hepatitis Therapeutic Revenue (US$ Million) & (2018-2023)
5.3.5 Generon corporation Recent Developments
5.4 Generon corporation
5.4.1 Generon corporation Profile
5.4.2 Generon corporation Main Business
5.4.3 Generon corporation Alcoholic Hepatitis Therapeutic Products, Services and Solutions
5.4.4 Generon corporation Alcoholic Hepatitis Therapeutic Revenue (US$ Million) & (2018-2023)
5.4.5 Generon corporation Recent Developments
5.5 Immuron limited
5.5.1 Immuron limited Profile
5.5.2 Immuron limited Main Business
5.5.3 Immuron limited Alcoholic Hepatitis Therapeutic Products, Services and Solutions
5.5.4 Immuron limited Alcoholic Hepatitis Therapeutic Revenue (US$ Million) & (2018-2023)
5.5.5 Immuron limited Recent Developments
5.6 Lupin Laboratories
5.6.1 Lupin Laboratories Profile
5.6.2 Lupin Laboratories Main Business
5.6.3 Lupin Laboratories Alcoholic Hepatitis Therapeutic Products, Services and Solutions
5.6.4 Lupin Laboratories Alcoholic Hepatitis Therapeutic Revenue (US$ Million) & (2018-2023)
5.6.5 Lupin Laboratories Recent Developments
5.7 Intercept Pharmaceuticals
5.7.1 Intercept Pharmaceuticals Profile
5.7.2 Intercept Pharmaceuticals Main Business
5.7.3 Intercept Pharmaceuticals Alcoholic Hepatitis Therapeutic Products, Services and Solutions
5.7.4 Intercept Pharmaceuticals Alcoholic Hepatitis Therapeutic Revenue (US$ Million) & (2018-2023)
5.7.5 Intercept Pharmaceuticals Recent Developments
5.8 Teva Pharmaceuticals
5.8.1 Teva Pharmaceuticals Profile
5.8.2 Teva Pharmaceuticals Main Business
5.8.3 Teva Pharmaceuticals Alcoholic Hepatitis Therapeutic Products, Services and Solutions
5.8.4 Teva Pharmaceuticals Alcoholic Hepatitis Therapeutic Revenue (US$ Million) & (2018-2023)
5.8.5 Teva Pharmaceuticals Recent Developments
5.9 Sanofi-Aventis
5.9.1 Sanofi-Aventis Profile
5.9.2 Sanofi-Aventis Main Business
5.9.3 Sanofi-Aventis Alcoholic Hepatitis Therapeutic Products, Services and Solutions
5.9.4 Sanofi-Aventis Alcoholic Hepatitis Therapeutic Revenue (US$ Million) & (2018-2023)
5.9.5 Sanofi-Aventis Recent Developments
6 North America
6.1 North America Alcoholic Hepatitis Therapeutic Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Alcoholic Hepatitis Therapeutic Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Alcoholic Hepatitis Therapeutic Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Alcoholic Hepatitis Therapeutic Market Dynamics
11.1 Alcoholic Hepatitis Therapeutic Industry Trends
11.2 Alcoholic Hepatitis Therapeutic Market Drivers
11.3 Alcoholic Hepatitis Therapeutic Market Challenges
11.4 Alcoholic Hepatitis Therapeutic Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
